BE703872A - - Google Patents

Info

Publication number
BE703872A
BE703872A BE703872DA BE703872A BE 703872 A BE703872 A BE 703872A BE 703872D A BE703872D A BE 703872DA BE 703872 A BE703872 A BE 703872A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE703872A publication Critical patent/BE703872A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE703872D 1966-09-15 1967-09-14 BE703872A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57948366A 1966-09-15 1966-09-15
US63865767A 1967-05-15 1967-05-15

Publications (1)

Publication Number Publication Date
BE703872A true BE703872A (fr) 1968-03-14

Family

ID=27077774

Family Applications (1)

Application Number Title Priority Date Filing Date
BE703872D BE703872A (fr) 1966-09-15 1967-09-14

Country Status (5)

Country Link
US (1) US3560501A (fr)
BE (1) BE703872A (fr)
ES (1) ES345003A1 (fr)
FR (2) FR6837M (fr)
NL (1) NL6712581A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897432A (en) * 1971-04-21 1975-07-29 Merck & Co Inc Substituted benzimidazole derivatives
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US4029792A (en) * 1972-02-29 1977-06-14 Pfizer Inc. (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
US3915976A (en) * 1972-09-01 1975-10-28 Sandoz Ag Substituted-4-phenyl-5h-cycloalkano(d)pyrimidines
JPS5271483A (en) * 1975-12-11 1977-06-14 Sumitomo Chem Co Ltd Synthesis of 2(1h)-quinazolinone derivatives
US6435468B1 (en) 2000-10-26 2002-08-20 Dror Simchoni Rolling weighted base
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
EP2329849B1 (fr) 2009-11-18 2015-04-29 Galderma Research & Development Combinaison d'un agoniste du récepteur alpha-2 adrénergique et d'un agent anti-inflammatoire non stéroïdien pour traiter ou empêcher un trouble cutané inflammatoire
US8394800B2 (en) * 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
CN103096894A (zh) 2010-03-26 2013-05-08 盖尔德马研究及发展公司 用于治疗红斑的包含溴莫尼定的组合物
KR20170018974A (ko) 2010-03-26 2017-02-20 갈데르마 리써어치 앤드 디벨로프먼트 홍반의 유효하고 안전한 치료를 위한 개선된 방법 및 조성물
AR083651A1 (es) 2010-10-21 2013-03-13 Galderma Sa Composiciones de brimonidina en gel y metodos de uso
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition

Also Published As

Publication number Publication date
US3560501A (en) 1971-02-02
ES345003A1 (es) 1969-01-01
NL6712581A (fr) 1968-03-18
FR6837M (fr) 1969-03-31
FR6845M (fr) 1969-04-08

Similar Documents

Publication Publication Date Title
AU5917865A (fr)
AU428063B2 (fr)
AU424443B2 (fr)
AU414526B2 (fr)
AU433222B2 (fr)
AU421822B2 (fr)
AU417216B2 (fr)
AU415165B1 (fr)
AU1144366A (fr)
AU6703465A (fr)
AU612166A (fr)
AU5895065A (fr)
AU1111066A (fr)
AU218666A (fr)
BE284991A (fr)
BE597652A (fr)
AU433620A (fr)
AU415780B2 (fr)
BE666282A (fr)
AU407778B2 (fr)
BE692708A (fr)
AU411645B2 (fr)
AU6852465A (fr)
AU855865A (fr)
AU92366A (fr)